Metabolic syndrome and ectopic fat deposition. What can CT and MR provide?

Academic Radiology

Volumn 17, Issue 10, 2010, Pages 1302-1312

  Meng, Kenneth ^a   Lee, Christopher H ^a   Saremi, Farhood ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

ATHEROGENESIS; BLOOD PRESSURE; CARDIOMYOPATHY; COMPUTER ASSISTED TOMOGRAPHY; CUSHING DISEASE; CYTOKINE PRODUCTION; DISEASE MARKER; GASTROINTESTINAL TRACT; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; INSULIN RESISTANCE; INTESTINE FUNCTION; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOMATOSIS; LIVER BIOPSY; LIVER CIRRHOSIS; MACROPHAGE; MAST CELL; METABOLIC SYNDROME X; NEEDLE BIOPSY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PANCREAS DISEASE; PANCREAS ISLET; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SINUS NODE; STEATOSIS; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; CHORISTOMA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; METABOLIC SYNDROME X; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956469321     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2010.03.019     Document Type: Review

References (53)

1. Grundy S.M. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28:629-636.
2. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection.
3. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
4. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
5. Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
6. Engeli S., Bohnke J., Feldpausch M., et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005, 54:2838-2843.
7. Bellocchio L., Vicennati V., Cervino C., et al. The endocannabinoid system in the regulation of cardiometabolic risk factors. Am J Cardiol 2007, 100:7P-17P.
8. Nieves D.J., Cnop M., Retzlaff B., et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003, 52:172-179.
9. Lau D.C., Dhillon B., Yan H., et al. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005, 288:H2031-H2041.
10. Després J.P., Lemieux I., Bergeron J., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
11. Yoshizumi T., Nakamura T., Yamane M., et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999, 211:283-286.
12. Taylor G. Good fat, bad fat-does location matter?. Radiology 2007, 242:645-646.
13. Sacks H.S., Fain J.N. Human epicardial adipose tissue: a review. Am Heart J 2007, 153:907-917.
14. Rabkin S.W. Epicardial fat: properties, function and relationship to obesity. Obes Rev 2007, 8:253-261.
15. Iacobellis G., Assael F., Ribaudo M.C., et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003, 11:304-310.
16. Marchington J.M., Mattacks C.A., Pond C.M. Adipose tissue in the mammalian heart and pericardium; structure, foetal development and biochemical properties. Comp Biochem Physiol 1989, 94B:225-232.
17. Mazurek T., Zhang L., Zalewski A., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
18. Bharati S., Lev M. Cardiac conduction system involvement in sudden death of obese young people. Am Heart J 1996, 129:273-281.
19. James T.N., St Martin E., Willis P.W., et al. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation 1996, 93:1424-1438.
20. Hutter A.M., Page D.L. Atrial arrhythmias and lipomatous hypertrophy of the cardiac interatrial septum. Am Heart J 1971, 82:16-21.
21. Kalman J.M., Olgin J.E., Karch M.R., et al. " Cristal tachycardias": origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography. J Am Coll Cardiol 1998, 31:451-459.
22. Nakagawa H., Lazzara R., Khastgir T., et al. Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter: relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation 1996, 94:407-424.
23. Ariyarajah V., Asad N., Tandar A., et al. Interatrial block: pandemic prevalence, significance, and diagnosis. Chest 2005, 128:970-975.
24. Saremi F., Channual S., Krishnan S., et al. Bachmann bundle and its arterial supply: imaging with multidetector CT-implications for interatrial conduction abnormalities and arrhythmias. Radiology 2008, 248:447-457.
25. McNamara R.F., Taylor A.E., Panner B.J. Superior vena caval obstruction by lipomatous hypertrophy of the right atrium. Clin Cardiol 1987, 10:609-610.
26. de Voogt W.G., Ruiter J.H. Occlusion of the coronary sinus: a complication of resynchronisation therapy for severe heart failure. Europace 2006, 8:456-458.
27. Tansey D.K., Aly Z., Sheppard M.N. Fat in the right ventricle of the normal heart. Histopathology 2005, 46:98-104.
28. Kessels K., Cramer M.J., Veldhuis B. Epicardial adipose tissue imaged by magnetic resonance imaging: an important risk marker of cardiovascular disease. Heart 2006, 92:262.
29. Ferraro S., Perrone-Filardi P., Desiderio A., et al. Left ventricular systolic and diastolic function in severe obesity: a radionuclide study. Cardiology 1996, 87:347-353.
30. Wong C.Y., O'Moore-Sullivan T., Leano R., et al. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004, 1(10):3081-3087.
31. Raney A.R., Saremi F., Kenchaiah S., et al. Multidetector computed tomography shows intramyocardial fat deposition. J Cardiovasc Comput Tomogr 2008, 2:152-163.
32. McKenna W.J., Thiene G., Nava A., et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994, 71:215-218.
33. Kimura F., Sakai F., Sakomura Y., et al. Helical CT features of arrhythmogenic right ventricular cardiomyopathy. Radiographics 2002, 22:1111-1124.
34. Litwin S.E. Cardiac remodeling in obesity: time for a new paradigm. JACC Cardiovasc Imaging 2010, 3:275-277.
35. van der Meer R.W., Doornbos J., Kozerke S., et al. Metabolic imaging of myocardial triglyceride: reproducibility of 1H-MR spectroscopy using respiratory navigator gating in volunteers. Radiology 2007, 245:251-257.
36. Kankaanpaa M., Lehto H.R., Parkka J.P., et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006, 91:4689-4695.
37. Mazhar S.M., Shiehmorteza M., Sirlin C.B. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009, 7:135-140.
38. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:S99-S112.
39. Ryan M.C., Wilson A.M., Slavin J., et al. Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Diabetes Care 2005, 28:1222-1224.
40. Ma X., Holalkere N.S., Kambadakone R.A., et al. Imaging-based quantification of hepatic fat: methods and clinical applications. RadioGraphics 2009, 29:1253-1280.
41. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
42. Lyznicki J.M., Young D.C., Riggs J.A., et al. Obesity: assessment and management in primary care. Am Fam Physician 2001, 63:2185-2196.
43. Elias J., Altun E., Zacks S., et al. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging. Magn Reson Imaging 2009, 27:976-987.
44. Raptopoulos V., Karellas A., Bernstein J., et al. Value of dual-energy CT in differentiating focal fatty infiltration of the liver from low-density masses. AJR Am J Roentgenol 1991, 157:721-725.
45. d'Assignies G Ruel M, Khiat A, at al. Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol 2009, 19:2033-2040.
46. Qayyum A. MR spectroscopy of the liver: principles and clinical applications. Radiographics 2009, 29:1653-1664.
47. Cowin G.J., Jonsson J.R., Bauer J.D., et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 2008, 28:937-945.
48. Mathur A., Marine M., Lu D., et al. Nonalcoholic fatty pancreas disease. HPB (Oxford) 2007, 9:312-318.
49. Lee J.S., Kim S.H., Jun D.W., et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009, 15:1869-1875.
50. Katz D.S., Hines J., Math K.R., et al. Using CT to reveal fat-containing abnormalities of the pancreas. AJR Am J Roentgenol 1999, 172:393-396.
51. Kim H.J., Byun J.H., Park S.H., et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. AJR Am J Roentgenol 2007, 188:429-432.
52. Rogers J., Stratta R.J., Lo A., et al. Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation. Transplant Proc 2005, 37:3549-3551.
53. Weiss R., Dufour S., Groszmann A. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003, 88:2014-2018.